Drug Delivery and Nanotechnology Group

Biomaterials are useful in drug delivery and targeting, since they can be optimized as controlled release formulations and also as nanoparticles for intracellular drug delivery. Our unique interdisciplinary research program couples both physico-chemical and biological aspects in this area. The research is focused in particular on continuous protein delivery from microencapsulated cells and on nanoparticle-mediated gene delivery and targeted anti-cancer drug research.

Arto Urtti, Ph.D, Group Leader

Professor Urtti has led the Centre for Drug Research (CDR) at the University of Helsinki since 2005. Professor Urtti’s has authored more than 220 peer-reviewed articles and 20 patents and patent applications.